Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AtriCure (ATRC) Other Accumulated Expenses (2016 - 2025)

AtriCure (ATRC) has disclosed Other Accumulated Expenses for 15 consecutive years, with $3.1 million as the latest value for Q4 2025.

  • Quarterly Other Accumulated Expenses rose 11.27% to $3.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.1 million through Dec 2025, up 11.27% year-over-year, with the annual reading at $3.1 million for FY2025, 11.27% up from the prior year.
  • Other Accumulated Expenses for Q4 2025 was $3.1 million at AtriCure, up from $3.0 million in the prior quarter.
  • The five-year high for Other Accumulated Expenses was $20.7 million in Q3 2023, with the low at $362000.0 in Q2 2021.
  • Average Other Accumulated Expenses over 5 years is $7.4 million, with a median of $4.6 million recorded in 2021.
  • Peak annual rise in Other Accumulated Expenses hit 1039.55% in 2021, while the deepest fall reached 95.3% in 2021.
  • Over 5 years, Other Accumulated Expenses stood at $1.8 million in 2021, then soared by 211.62% to $5.5 million in 2022, then skyrocketed by 278.33% to $20.7 million in 2023, then crashed by 86.45% to $2.8 million in 2024, then grew by 11.27% to $3.1 million in 2025.
  • According to Business Quant data, Other Accumulated Expenses over the past three periods came in at $3.1 million, $3.0 million, and $2.8 million for Q4 2025, Q3 2025, and Q4 2024 respectively.